DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,308 | +3.9% | 21,395 | +0.5% | 1.44% | +8.6% |
| Q2 2023 | $5,109 | -99.9% | 21,289 | -2.0% | 1.33% | -7.3% |
| Q1 2023 | $5,473,784 | +92191.1% | 21,718 | -2.8% | 1.44% | -8.8% |
| Q4 2022 | $5,931 | -99.9% | 22,347 | +14.7% | 1.58% | +13.6% |
| Q3 2022 | $5,034,000 | +9.7% | 19,489 | +7.7% | 1.39% | +5.6% |
| Q2 2022 | $4,590,000 | -10.9% | 18,104 | +3.1% | 1.31% | -1.3% |
| Q1 2022 | $5,153,000 | -9.3% | 17,568 | +1.8% | 1.33% | +1.1% |
| Q4 2021 | $5,680,000 | +18.6% | 17,265 | +9.7% | 1.31% | +5.6% |
| Q3 2021 | $4,789,000 | +17.1% | 15,733 | +3.2% | 1.24% | +19.4% |
| Q2 2021 | $4,090,000 | +23.8% | 15,241 | +3.9% | 1.04% | +12.9% |
| Q1 2021 | $3,303,000 | +7.8% | 14,675 | +6.4% | 0.92% | -0.5% |
| Q4 2020 | $3,065,000 | +20.4% | 13,797 | +16.7% | 0.93% | +1.5% |
| Q3 2020 | $2,545,000 | +30.0% | 11,820 | +6.8% | 0.91% | +5.2% |
| Q2 2020 | $1,957,000 | +29.5% | 11,065 | +1.3% | 0.87% | +12.0% |
| Q1 2020 | $1,511,000 | -17.9% | 10,919 | -8.9% | 0.78% | -9.6% |
| Q4 2019 | $1,840,000 | +6.2% | 11,990 | -0.0% | 0.86% | -17.0% |
| Q3 2019 | $1,732,000 | +0.8% | 11,992 | -0.3% | 1.03% | -2.6% |
| Q2 2019 | $1,719,000 | +8.0% | 12,031 | -0.2% | 1.06% | +4.1% |
| Q1 2019 | $1,592,000 | +27.3% | 12,059 | -0.6% | 1.02% | +14.5% |
| Q4 2018 | $1,251,000 | -3.7% | 12,132 | +1.5% | 0.89% | +27.8% |
| Q3 2018 | $1,299,000 | +12.0% | 11,952 | +1.7% | 0.70% | -5.3% |
| Q2 2018 | $1,160,000 | -5.7% | 11,752 | -6.5% | 0.74% | -6.1% |
| Q1 2018 | $1,230,000 | +6.9% | 12,565 | +1.3% | 0.78% | +7.1% |
| Q4 2017 | $1,151,000 | +6.6% | 12,404 | -1.5% | 0.73% | +2.2% |
| Q3 2017 | $1,080,000 | -7.0% | 12,593 | -8.4% | 0.72% | -8.9% |
| Q2 2017 | $1,161,000 | +0.3% | 13,754 | +1.7% | 0.79% | -5.9% |
| Q1 2017 | $1,157,000 | +54.3% | 13,530 | +40.5% | 0.84% | +47.5% |
| Q4 2016 | $750,000 | +519.8% | 9,633 | +641.0% | 0.57% | +686.1% |
| Q4 2015 | $121,000 | – | 1,300 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |